Despite innovative advances in anti-infective therapies and vaccine development
technologies, community-acquired pneumonia (CAP) remains the most persistent cause of …

Background: Considering the global burden of pulmonary infections, there is an urgent need
for optimal empirical antimicrobial therapy strategies for pulmonary infections, which should …

Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality
worldwide. This retrospective observational study evaluated the antibiotic prescription …

Background The objective of this network meta-analysis was to compare rates of clinical
response and mortality for empiric oral antibiotic regimens in adults with mild-moderate …

Objectives This network meta-analysis aimed to compare the efficacy and safety of
fluoroquinolone (FQ) monotherapy, β-lactam (BL) monotherapy and β-lactam/macrolide (BL …

Moxifloxacin is a potent fluoroquinolone antibiotic that is effective against a wide range of
bacterial infections. Bayer AG developed the drug in the late 1990s, and it received approval …

Purpose The cost-effectiveness of different guideline-concordant antimicrobial regimens for
elderly patients with community-acquired pneumonia (CAP) was rarely discussed. This …

Antimicrobial resistance is a global crisis. Prescribing antibacterial combinations may be
one way of reducing the development of resistance in target pathogens, as in the treatment …

Metode: Penelitian retrospektif ini melibatkan pasien dengan community acquired
pneumonia yang menerima terapi empiris antara Januari-Desember 2017 di Rumah Sakit …

摘要目的探讨基因PPARG rs2290449 的单核苷酸多态性与脓毒症伴多器官功能障碍综合征(
MODS) 联合用药疗效的相关性. 方法选择382 例接受联合用药治疗的脓毒症伴MODS 患者 …